Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD).

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Behavioural Brain Research

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/j.bbr.2012.07.004PMID 22796601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurologic function during developmental and adult stages in Dab1(scm) (scrambler) mutant mice.

  2012cited by this paper
• Behavioral Defects in Chaperone-Deficient Alzheimer's Disease Model Mice

  2011cited by this paper
• Orally Administrated Cinnamon Extract Reduces β-Amyloid Oligomerization and Corrects Cognitive Impairment in Alzheimer's Disease Animal Models

  2011cited by this paper
• P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating

  2011cited by this paper
• DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD Mice

  2011cited by this paper
• Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology

  2010cited by this paper
• CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease

  2010cited by this paper
• Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice.

  2010cited by this paper
• Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.

  2010cited by this paper
• A Noncompetitive BACE1 Inhibitor TAK-070 Ameliorates Aβ Pathology and Behavioral Deficits in a Mouse Model of Alzheimer's Disease

  2010cited by this paper
• Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction

  2010cited by this paper
• Generation and Therapeutic Efficacy of Highly Oligomer-Specific β-Amyloid Antibodies

  2010cited by this paper
• Age-dependent sexual dimorphisms in cognition and stress response in the 3xTg-AD mice

  2009cited by this paper
• Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition.

  2009cited by this paper
• Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

  2009cited by this paper
• The Vps33a gene regulates behavior and cerebellar Purkinje cell number.

  2009cited by this paper
• Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease

  2009cited by this paper
• Validation of a 2-day water maze protocol in mice.

  2009cited by this paper
• Limited impact of social isolation on Alzheimer-like symptoms in a triple transgenic mouse model.

  2009cited by this paper
• Cognitive and non‐cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer’s disease

  2009cited by this paper
• Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses.

  2009cited by this paper
• Combination of modified SHIRPA and pharmacological approach uncovers neuronal alteration in senescence-accelerated mouse prone 6 (SAMP6) strain.

  2009cited by this paper
• Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy

  2009cited by this paper
• Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease.

  2009cited by this paper
• Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease.

  2008cited by this paper
• Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's‐disease‐model transgenic mice shown as by micromagnetic resonance imaging

  2008cited by this paper
• Age-dependent and -independent behavioral deficits in Tg2576 mice.

  2008cited by this paper
• Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice.

  2008cited by this paper
• Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice.

  2008cited by this paper
• Ataxia with loss of Purkinje cells in a mouse model for Refsum disease

  2008cited by this paper
• Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.

  2007cited by this paper
• Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice

  2007cited by this paper
• Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice.

  2007cited by this paper
• Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease.

  2007cited by this paper
• Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial Dysfunction

  2006cited by this paper
• Locus Ceruleus Degeneration Promotes Alzheimer Pathogenesis in Amyloid Precursor Protein 23 Transgenic Mice

  2006cited by this paper
• Progressive cognitive decline in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe

  2006cited by this paper
• Neprilysin-sensitive Synapse-associated Amyloid-β Peptide Oligomers Impair Neuronal Plasticity and Cognitive Function*

  2006cited by this paper
• Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside.

  2006cited by this paper
• Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice

  2005cited by this paper
• Behavioural characterization of vitamin D receptor knockout mice.

  2005cited by this paper
• Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen.

  2005cited by this paper
• Primary neurologic screening and motor coordination of Dstdt-J mutant mice (dystonia musculorum) with spinocerebellar atrophy.

  2005cited by this paper
• Alzheimer disease without neocortical neurofibrillary tangles

  2004cited by this paper
• Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes.

  2004cited by this paper
• Spermidine/spermine N1-acetyltransferase overexpression in mice induces hypoactivity and spatial learning impairment.

  2004cited by this paper
• A novel mutation (L250V) in the presenilin 1 gene in a Japanese familial Alzheimer's disease with myoclonus and generalized convulsion.

  2003cited by this paper
• Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

  2003cited by this paper
• Transgenic mice expressing the βAPP695SWE mutation: effects on exploratory activity, anxiety, and motor coordination

  2003cited by this paper
• Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.

  2003influential reference
• The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice.

  2002cited by this paper
• Hippocampal Aβ42 Levels Correlate with Spatial Memory Deficit in APP and PS1 Double Transgenic Mice

  2002cited by this paper
• Does my mouse have Alzheimer's disease?

  2002cited by this paper
• Neuronal Deficiency of Presenilin 1 Inhibits Amyloid Plaque Formation and Corrects Hippocampal Long-Term Potentiation But Not a Cognitive Defect of Amyloid Precursor Protein [V717I] Transgenic Mice

  2002cited by this paper
• Transgenic mouse models of Alzheimer's disease.

  2001cited by this paper
• Development of SHIRPA to characterise the phenotype of gene-targeted mice.

  2001cited by this paper
• Motor learning in Ts65Dn mice, a model for Down syndrome.

  2001cited by this paper
• Single and multiple transgenic mice as models for Alzheimer's disease.

  2000cited by this paper
• Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation.

  2000cited by this paper
• Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmdmdx and Dmdmdx3cv dystrophin-deficient mice

  2000cited by this paper
• Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain*

  1999cited by this paper
• Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein.

  1999cited by this paper
• Transgenic mice expressing Alzheimer amyloid precursor proteins.

  1998cited by this paper
• Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice.

  1998cited by this paper
• A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years.

  1996cited by this paper
• Seizures in Alzheimer's Disease: Clinicopathologic Study

  1994cited by this paper
• Brain Cytochrome Oxidase in Alzheimer's Disease

  1992cited by this paper

• Comparison of treatment schedules on cognitive effects of rTMS in the 3xTg-AD model of Alzheimer's disease.

  2025cites this paper
• Stem cell therapy offers new hope for the treatment of Alzheimer’s disease

  2025cites this paper
• 头戴式小型化显微镜在脑科学研究中的进展（特邀）

  2025cites this paper
• An Overview of Transgenic Mouse Models for the Study of Alzheimer’s Disease

  2025cites this paper
• Motor deficits in the McGill-R-Thy1-APP transgenic rat model of Alzheimer’s Disease

  2025cites this paper
• Exercise Improves Alzheimer’s Disease Phenotype in the TgF344-AD Rat, a Behavioral Time Course Study of Males and Females

  2025cites this paper
• Advancement in modeling of Alzheimer’s disease: a comprehensive review of preclinical screening platforms

  2025cites this paper
• rTMS Modulation of Behavioral and Biological Measures in 3xTg-AD Mice

  2024influential citation
• Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research

  2024cites this paper
• Systemic Treatment with siRNA Targeting Gamma-Secretase Activating Protein Inhibits Amyloid-β Accumulation in Alzheimer’s Disease

  2024cites this paper
• Rodent Models of Alzheimer’s Disease: Past Misconceptions and Future Prospects

  2024cites this paper
• Combining supervised and unsupervised analyses to quantify behavioral phenotypes and validate therapeutic efficacy in a triple transgenic mouse model of Alzheimer’s disease

  2024cites this paper
• Combining supervised and unsupervised analyses to quantify behavioral phenotypes and validate therapeutic efficacy in a triple transgenic mouse model of Alzheimer’s disease

  2024cites this paper
• Epigenetic Inhibitors as Alzheimer's Disease Therapeutic Agents.

  2024cites this paper
• Curcumin Mitigates the High-Fat High-Sugar Diet-Induced Impairment of Spatial Memory, Hepatic Metabolism, and the Alteration of the Gut Microbiome in Alzheimer’s Disease-Induced (3xTg-AD) Mice

  2024cites this paper
• Pros and cons of narrow- versus wide-compartment rotarod apparatus: an experimental study in mice.

  2024cites this paper
• Impact of Interleukin-34 on the Promotion of Bone Osteolysis and Neuroinflammation in Experimental Models of Alzheimer’S Disease

  2023cites this paper
• Anxiety and Alzheimer’s disease pathogenesis: focus on 5-HT and CRF systems in 3xTg-AD and TgF344-AD animal models

  2023cites this paper
• Cognitive Trajectories in Longitudinally Trained 3xTg-AD Mice.

  2023cites this paper
• Assessment of Lab4P Probiotic Effects on Cognition in 3xTg-AD Alzheimer’s Disease Model Mice and the SH-SY5Y Neuronal Cell Line

  2023influential citation
• Administration of recombinant FOXN1 protein attenuates Alzheimer's pathology in mice.

  2023cites this paper
• Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer’s disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway

  2023cites this paper
• Enhancing autophagy maturation with CCZ1-MON1A complex alleviates neuropathology and memory defects in Alzheimer disease models

  2022cites this paper
• Prenatal alcohol exposure causes persistent microglial activation and age- and sex- specific effects on cognition and metabolic outcomes in an Alzheimer’s Disease mouse model

  2022cites this paper
• Abnormal whisker movements in the 3xTg‐AD mouse model of Alzheimer's disease

  2022cites this paper
• Impact of Behavioral Assessment and Re-Test as Functional Trainings That Modify Survival, Anxiety and Functional Profile (Physical Endurance and Motor Learning) of Old Male and Female 3xTg-AD Mice and NTg Mice with Normal Aging

  2022cites this paper
• Heightened Tameness and Accelerated Handling-Habituation in 3×Tg-AD Mice on a B6;129 Genetic Background

  2022cites this paper
• Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer’s Disease

  2022cites this paper
• Triiodothyronine Treatment reverses Depression-Like Behavior in a triple-transgenic animal model of Alzheimer’s Disease

  2022cites this paper
• Low-Dose Radiation Therapy Reduces Amyloid Load in Young 3xTg-AD Mice

  2022cites this paper
• Multifocal Cerebral Microinfarcts Modulate Early Alzheimer’s Disease Pathology in a Sex-Dependent Manner

  2022cites this paper
• The effect of exercise on early sensorimotor performance alterations in the 3xTg-AD model of Alzheimer's disease.

  2022cites this paper
• Plaque-Associated Oligomeric Amyloid-Beta Drives Early Synaptotoxicity in APP/PS1 Mice Hippocampus: Ultrastructural Pathology Analysis

  2021cites this paper
• Alleviation Effects of Bifidobacterium animalis subsp. lactis XLTG11 on Dextran Sulfate Sodium-Induced Colitis in Mice

  2021cites this paper
• Preserved Thermal Pain in 3xTg-AD Mice With Increased Sensory-Discriminative Pain Sensitivity in Females but Affective-Emotional Dimension in Males as Early Sex-Specific AD-Phenotype Biomarkers

  2021cites this paper
• Progressive impairments in executive function in the APP/PS1 model of Alzheimer's disease as measured by translatable touchscreen testing.

  2021cites this paper
• SHIRPA as a Neurological Screening Battery in Mice

  2021cites this paper
• Patterns of cognitive decline and somatosensory processing in a mouse model of amyloid accumulation

  2021cites this paper
• Intranasal Paclitaxel Alters Alzheimer’s Disease Phenotypic Features in 3xTg-AD Mice

  2021cites this paper
• Therapeutic B-cell depletion reverses progression of Alzheimer’s disease

  2021cites this paper
• Age and Gender Differences for the Behavioral Phenotypes of 3xTg Alzheimer's Disease mice.

  2021cites this paper
• Deciphering Brain Function by Miniaturized Fluorescence Microscopy in Freely Behaving Animals

  2020cites this paper
• Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease-related pathology: Running title: BPSD in Alzheimer's disease models.

  2020cites this paper
• How can preclinical cognitive research further neuropsychiatric drug discovery? Chances and challenges

  2020cites this paper
• Reorientation by features and geometry: Effects of healthy and degenerative age-related cognitive decline

  2020cites this paper
• In Vitro and In Vivo Effects of Radio- Frequency Electromagnetic Fields

  2020cites this paper
• Dickkopf-related protein-1 inhibition attenuates amyloid-beta pathology associated to Alzheimer's disease.

  2020cites this paper
• Abnormal brain structure and behavior in MyD88-deficient mice.

  2020cites this paper
• Enhancing microtubule stabilization rescues cognitive deficits and ameliorates pathological phenotype in an amyloidogenic Alzheimer’s disease model

  2020cites this paper
• Chronic airway allergy induces pro-inflammatory responses in the brain of wildtype mice but not 3xTgAD mice.

  2020cites this paper
• Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease

  2020cites this paper
• Naringin Attenuates Aluminum Induced Cognitive Deficits in Rats

  2020cites this paper
• Efecto del Bexaroteno sobre la plasticidad en la sinapsis comisural CA3-CA1 en un modelo murino de enfermedad de Alzheimer.

  2019cites this paper
• Alcohol Drinking Exacerbates Neural and Behavioral Pathology in the 3xTg-AD Mouse Model of Alzheimer’s Disease

  2019cites this paper
• Progressive impairments in executive function in the APP/PS1 model of Alzheimer’s disease as measured by translatable touchscreen testing

  2019cites this paper
• Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer’s Disease

  2019cites this paper
• Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer’s Disease and Parkinson’s Disease

  2019cites this paper
• Motor deficits in 16‐month‐old male and female 3xTg‐AD mice

  2019cites this paper
• Dissociable cognitive impairments in two strains of transgenic Alzheimer’s disease mice revealed by a battery of object-based tests

  2019cites this paper
• A longitudinal multimodal in vivo molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss

  2019cites this paper
• Altered slow (<1 Hz) and fast (beta and gamma) neocortical oscillations in the 3xTg-AD mouse model of Alzheimer's disease under anesthesia.

  2019cites this paper
• Analysis of Motor Function in the Tg4-42 Mouse Model of Alzheimer’s Disease

  2019cites this paper
• Intraneuronal accumulation of C99 contributes to synaptic alterations, apathy-like behavior, and spatial learning deficits in 3×TgAD and 2×TgAD mice.

  2018cites this paper
• Investigating mechanisms of pain in Alzheimer's disease

  2018cites this paper
• A novel GLP‐1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease

  2018influential citation
• Aging exacerbates cognitive and anxiety alterations induced by an intracerebroventricular injection of amyloid‐&bgr;1–42 peptide in mice

  2018cites this paper
• Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer’s Disease

  2018cites this paper
• Early Intervention with a Multi-Ingredient Dietary Supplement Improves Mood and Spatial Memory in a Triple Transgenic Mouse Model of Alzheimer’s Disease

  2018cites this paper
• Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis

  2018cites this paper
• Overexpression of EphB2 in hippocampus rescues impaired NMDA receptors trafficking and cognitive dysfunction in Alzheimer model

  2017cites this paper
• EFFECTS OF THE NOVEL IDO INHIBITOR DWG-1036 ON THE BEHAVIOUR AND NEUROCHEMISTRY OF THE TRIPLE TRANSGENIC MOUSE MODEL OF ALZHEIMER’S DISEASE

  2017cites this paper
• Citalopram Ameliorates Impairments in Spatial Memory and Synaptic Plasticity in Female 3xTgAD Mice

  2017cites this paper
• NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer’s, and Ethanol Intoxication

  2017cites this paper
• Swimming exercise prevents behavioural disturbances induced by an intracerebroventricular injection of amyloid‐&bgr;1‐42 peptide through modulation of cytokine/NF‐kappaB pathway and indoleamine‐2,3‐dioxygenase in mouse brain

  2017cites this paper
• Assessing the Relationship of White Matter Hyperintensities and Grey Matter to Neuropsychiatric Symptoms in Alzheimer's Disease and Mild Cognitive Impairment

  2017cites this paper
• The Impact of Ultrasound on APP/PS1 Model Mouse

  2017cites this paper
• Differential Fasting Plasma Glucose and Ketone Body Levels in GHRKO versus 3xTg-AD Mice: A Potential Contributor to Aging-Related Cognitive Status?

  2017cites this paper
• Agmatine ameliorates type 2 diabetes induced‐Alzheimer's disease‐like alterations in high‐fat diet‐fed mice via reactivation of blunted insulin signalling

  2017cites this paper
• An Intracellular Amyloid-β/AβPP Epitope Correlates with Neurodegeneration in those Neuronal Populations Early Involved in Alzheimer’s Disease

  2017cites this paper
• Impaired retention of depression-like behavior in a mouse model of Alzheimer's disease

  2017cites this paper
• Effects of Nobiletin in Animal Models of Cognitive Impairment: Current Insights and Future Perspectives

  2017cites this paper
• Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease

  2017cites this paper
• Acquisition and reversal of visual discrimination learning in APPSwDI/Nos2-/- (CVN) mice.

  2017cites this paper
• Citalopram restores short‐term memory deficit and non‐cognitive behaviors in APP/PS1 mice while halting the advance of Alzheimer's disease‐like pathology

  2017cites this paper
• Rendimiento cognitivo en envejecimiento: efecto del sueño, del ejercicio y de la TMS en Octodon degus

  2017cites this paper
• Impaired thermoregulation and beneficial effects of thermoneutrality in the 3×Tg-AD model of Alzheimer's disease.

  2016cites this paper
• The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer’s Disease

  2016cites this paper
• Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease

  2016cites this paper
• High fat diet exacerbates Alzheimer's disease-related pathology in APPswe/PS1 mice

  2016cites this paper
• Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice

  2016cites this paper
• Metabolic changes over the course of aging in a mouse model of tau deposition.

  2016cites this paper
• Impaired Memory and Evidence of Histopathology in CA1 Pyramidal Neurons through Injection of Aβ1-42 Peptides into the Frontal Cortices of Rat

  2016cites this paper
• The scent of stress: environmental challenge in the peripartum environment of mice affects emotional behaviours of the adult offspring in a sex-specific manner

  2016cites this paper
• Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer’s Disease and Dementia

  2016cites this paper
• The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice.

  2016cites this paper
• Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.

  2016influential citation
• Effects of Embryo Transfer on Emotional Behaviors in C57BL/6 Mice.

  2016cites this paper
• Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer’s Disease

  2016cites this paper
• Effect of CNTF Derived Peptide, P021 on Cognition and Pathology in 3xTG-AD Mouse Model of Alzheimer's Disease

  2016cites this paper
• Valoración clínica del dolor en el deterioro cognitivo

  2016cites this paper